125 related articles for article (PubMed ID: 37840320)
1. Predictive factors and oncological outcomes of pathological T3a upstaging in patients with clinical T1 renal cell carcinoma undergoing partial nephrectomy.
Ishiyama R; Omae K; Kondo T; Iizuka J; Yoshida K; Fukuda H; Tachibana H; Ishihara H; Kobayashi H; Takagi T
Jpn J Clin Oncol; 2024 Feb; 54(2):160-166. PubMed ID: 37840320
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of renal tumor contour irregularity score in pathological T3a upstaging of clinical T1 renal cell carcinoma: A multi-institutional study.
Xu P; Zhang S; Cao B; Li Y; Huang J; Lin W; Cheng J; Li H; Chen W; Zhu Y; Jiang S; Hu X; Wu J; Wu Z; Zhou J; Guo J; Wang H
Urol Oncol; 2022 May; 40(5):199.e1-199.e8. PubMed ID: 35365414
[TBL] [Abstract][Full Text] [Related]
3. Pathological T3a Upstaging of Clinical T1 Renal Cell Carcinoma: Outcomes According to Surgical Technique and Predictors of Upstaging.
Jeong SH; Kim JK; Park J; Jeon HJ; Yoon MY; Jeong CW; Ku JH; Kim HH; Kwak C
PLoS One; 2016; 11(11):e0166183. PubMed ID: 27861519
[TBL] [Abstract][Full Text] [Related]
4. Clinical impact of segmental renal vein invasion on recurrence in patients with clinical T1 renal cell carcinoma undergoing partial nephrectomy.
Yoshida T; Ohe C; Tsuzuki T; Sugi M; Kinoshita H; Tsuta K; Matsuda T
Int J Clin Oncol; 2020 Mar; 25(3):464-471. PubMed ID: 31531786
[TBL] [Abstract][Full Text] [Related]
5. Risk Factors for Upstaging, Recurrence, and Mortality in Clinical T1-2 Renal Cell Carcinoma Patients Upstaged to pT3a Disease: An International Analysis Utilizing the 8th Edition of the Tumor-Node-Metastasis Staging Criteria.
Hamilton ZA; Capitanio U; Pruthi D; Ghali F; Larcher A; Patel DN; Eldefrawy A; Patel S; Cotta BH; Bradshaw AW; Meagher MF; Miller NS; Carenzi C; Wan F; Liss MA; McGregor T; Montorsi F; Derweesh IH
Urology; 2020 Apr; 138():60-68. PubMed ID: 31836465
[TBL] [Abstract][Full Text] [Related]
6. Pathological Upstaging of Clinical T1 to Pathological T3a Renal Cell Carcinoma: A Multi-institutional Analysis of Short-term Outcomes.
Nayak JG; Patel P; Saarela O; Liu Z; Kapoor A; Finelli A; Tanguay S; Rendon R; Moore R; Black PC; Lacombe L; Breau RH; Kawakami J; Drachenberg DE
Urology; 2016 Aug; 94():154-60. PubMed ID: 27041471
[TBL] [Abstract][Full Text] [Related]
7. Survival Analysis of Pathological T3a Upstaging in Clinical T1 Renal Cell Carcinoma.
Lai GS; Li JR; Wang SS; Chen CS; Yang CK; Hung SC; Cheng CL; Ou YC; Chiu KY
In Vivo; 2020; 34(2):799-805. PubMed ID: 32111787
[TBL] [Abstract][Full Text] [Related]
8. Multi-institutional Survival Analysis of Incidental Pathologic T3a Upstaging in Clinical T1 Renal Cell Carcinoma Following Partial Nephrectomy.
Russell CM; Lebastchi AH; Chipollini J; Niemann A; Mehra R; Morgan TM; Miller DC; Palapattu GS; Hafez KS; Sexton WJ; Spiess PE; Weizer AZ
Urology; 2018 Jul; 117():95-100. PubMed ID: 29678662
[TBL] [Abstract][Full Text] [Related]
9. Partial Nephrectomy is Associated with Higher Risk of Relapse Compared with Radical Nephrectomy for Clinical Stage T1 Renal Cell Carcinoma Pathologically Up Staged to T3a.
Shah PH; Moreira DM; Patel VR; Gaunay G; George AK; Alom M; Kozel Z; Yaskiv O; Hall SJ; Schwartz MJ; Vira MA; Richstone L; Kavoussi LR
J Urol; 2017 Aug; 198(2):289-296. PubMed ID: 28274620
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors and Oncologic Outcomes for Clinical T1 Renal Cell Carcinoma Upstaging to Pathological T3a and The Construction of Predictive Model: A Retrospective Study.
Wang H; Wang K; Liu C; Wang G; Liu Y; Li G
Urol J; 2023 May; 20(3):148-156. PubMed ID: 36382432
[TBL] [Abstract][Full Text] [Related]
11. Partial nephrectomy versus radical nephrectomy for non-metastatic pathological T3a renal cell carcinoma: a multi-institutional comparative analysis.
Oh JJ; Byun SS; Lee SE; Hong SK; Lee ES; Kim HH; Kwak C; Ku JH; Jeong CW; Kim YJ; Kang SH; Hong SH
Int J Urol; 2014 Apr; 21(4):352-7. PubMed ID: 24118633
[TBL] [Abstract][Full Text] [Related]
12. Significance of Pathologic T3a Upstaging in Clinical T1 Renal Masses Undergoing Nephrectomy.
Ramaswamy K; Kheterpal E; Pham H; Mohan S; Stifelman M; Taneja S; Huang WC
Clin Genitourin Cancer; 2015 Aug; 13(4):344-349. PubMed ID: 25680295
[TBL] [Abstract][Full Text] [Related]
13. Perioperative morbidity, oncological outcomes and predictors of pT3a upstaging for patients undergoing partial nephrectomy for cT1 tumors.
Mouracade P; Kara O; Dagenais J; Maurice MJ; Nelson RJ; Malkoc E; Kaouk JH
World J Urol; 2017 Sep; 35(9):1425-1433. PubMed ID: 28197727
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of pathologic stage T3a renal cell carcinoma up-staged from small renal tumor: emphasis on partial nephrectomy.
Lee H; Lee M; Lee SE; Byun SS; Kim HH; Kwak C; Hong SK
BMC Cancer; 2018 Apr; 18(1):427. PubMed ID: 29661179
[TBL] [Abstract][Full Text] [Related]
15. Outcomes and predictors of clinical T1 to pathological T3a tumor up-staging after robotic partial nephrectomy: a multi-institutional analysis.
Gorin MA; Ball MW; Pierorazio PM; Tanagho YS; Bhayani SB; Kaouk JH; Rogers CG; Stifelman MD; Khalifeh A; Kumar R; Sivarajan G; Allaf ME
J Urol; 2013 Nov; 190(5):1907-11. PubMed ID: 23764083
[TBL] [Abstract][Full Text] [Related]
16. Association between renal mass biopsy and upstaging to perinephric fat involvement in a contemporary cohort of patients with clinical T1a renal cell carcinoma.
Salmasi A; Faiena I; Lenis AT; Pooli A; Johnson DC; Drakaki A; Gollapudi K; Blumberg J; Pantuck AJ; Chamie K
Urol Oncol; 2018 Dec; 36(12):527.e13-527.e19. PubMed ID: 30228094
[TBL] [Abstract][Full Text] [Related]
17. Risk factors and prognostic implications for pathologic upstaging to T3a after partial nephrectomy.
Beksac AT; Paulucci DJ; Gul Z; Reddy BN; Kannappan M; Martini A; Sfakianos JP; Gin GE; Abaza R; Eun DD; Bhandari A; Hemal AK; Porter J; Badani KK
Minerva Urol Nefrol; 2019 Aug; 71(4):395-405. PubMed ID: 30230296
[TBL] [Abstract][Full Text] [Related]
18. Pathological upstaging of clinical T1 renal cell carcinoma: an analysis of 115,835 patients from National Cancer Data Base, 2004-2013.
Ghanie A; Formica MK; Wang D; Bratslavsky G; Stewart T
Int Urol Nephrol; 2018 Feb; 50(2):237-245. PubMed ID: 29247309
[TBL] [Abstract][Full Text] [Related]
19. A novel nomogram can predict pathological T3a upstaged from clinical T1a in localized renal cell carcinoma.
Cao C; Kang X; Shang B; Shou J; Shi H; Jiang W; Xie R; Zhang J; Zhang L; Zheng S; Bi X; Li C; Ma J
Int Braz J Urol; 2022; 48(5):784-794. PubMed ID: 35838503
[TBL] [Abstract][Full Text] [Related]
20. Prognostic features of upstaged pT3a renal tumors with fat invasion after robot-assisted partial nephrectomy: is it time for a new subclassification?
Di Maida F; Campi R; Grosso AA; Lambertini L; Cadenar A; Giudici S; Pecoraro A; Mari A; Serni S; Minervini A;
Eur J Surg Oncol; 2023 Apr; 49(4):862-867. PubMed ID: 36528511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]